• Something wrong with this record ?

Clinical and molecular-genetic markers of ADHD in children

I Drtilkova, O Sery, P Theiner, A Uhrova, M Zackova, B Balastikova, V Znojil

. 2008 ; 29 (3) : 320-327.

Language English Country Sweden

Grant support
NR9298 MZ0 CEP Register

OBJECTIVES: The objective was to make a contribution to deepening the knowledge of the etiopathogenesis of ADHD. DESIGN: In an association study design, an analysis of polymorphisms of selected genes was conducted in 119 hyperkinetic boys and a control group of boys, aged 7-13. Furthermore several psychologically determined subgroups were identified. A connection between psychological functions (endophenotypes) and genes were looked for. RESULTS: There was a statistically significant difference found in allelic and genotype frequencies of the TaqI A polymorphism of the DRD2 gene. The frequency of the allele A1 in hyperkinetic boys and the control subjects was 0.26 and 0.15, respectively (p<0.003). A statistically significant occurrence of atypical genotypes (8/10, 7/10 and 10/11) of the DAT1 gene was also found in hyperkinetic boys and a connection between the M235 polymorphism of the angiotensinogene gene and the positive family history of psychiatric illness was found in probands (p=0.031). Significant correlations between the results of some neuropsychological tests and genes for neuro-/immunomodulators (IL-6, TNF-alpha) and the gene for the brain-derived neurotrophic factor (BDNF) were found. CONCLUSION: The study showed a statistically significant prevalence of A1 allele of the DRD gene in the hyperkinetic group. We also found a significantly higher incidence of atypical DAT genotypes in the hyperkinetic group. Furthermore we found significant connections with particular gene polymorphisms which may hypothetically represent a neurodevelopmental risk factor in the etiopathogenesis of the disorder (IL-2, IL-6, TNF-alpha, BDNF). We further found a connection of the M235 polymorphism of the AGT (angiotensinogene) gene to positive family history of psychiatric illness (p=0.031). As for cognitive characteristics, we identified three subtypes with different cognitive performance profiles. This finding shows interindividual variability of cognitive style in the group of hyperkinetic boys.

000      
02306naa 2200565 a 4500
001      
bmc11003996
003      
CZ-PrNML
005      
20140307115659.0
008      
110303s2008 sw e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Drtílková, Ivana, $d 1944- $7 nlk20040156087
245    10
$a Clinical and molecular-genetic markers of ADHD in children / $c I Drtilkova, O Sery, P Theiner, A Uhrova, M Zackova, B Balastikova, V Znojil
314    __
$a Department of Psychiatry, Faculty Hospital and Masaryk University Brno, Czech Republic. idrtilkova@fnbrno.cz
520    9_
$a OBJECTIVES: The objective was to make a contribution to deepening the knowledge of the etiopathogenesis of ADHD. DESIGN: In an association study design, an analysis of polymorphisms of selected genes was conducted in 119 hyperkinetic boys and a control group of boys, aged 7-13. Furthermore several psychologically determined subgroups were identified. A connection between psychological functions (endophenotypes) and genes were looked for. RESULTS: There was a statistically significant difference found in allelic and genotype frequencies of the TaqI A polymorphism of the DRD2 gene. The frequency of the allele A1 in hyperkinetic boys and the control subjects was 0.26 and 0.15, respectively (p<0.003). A statistically significant occurrence of atypical genotypes (8/10, 7/10 and 10/11) of the DAT1 gene was also found in hyperkinetic boys and a connection between the M235 polymorphism of the angiotensinogene gene and the positive family history of psychiatric illness was found in probands (p=0.031). Significant correlations between the results of some neuropsychological tests and genes for neuro-/immunomodulators (IL-6, TNF-alpha) and the gene for the brain-derived neurotrophic factor (BDNF) were found. CONCLUSION: The study showed a statistically significant prevalence of A1 allele of the DRD gene in the hyperkinetic group. We also found a significantly higher incidence of atypical DAT genotypes in the hyperkinetic group. Furthermore we found significant connections with particular gene polymorphisms which may hypothetically represent a neurodevelopmental risk factor in the etiopathogenesis of the disorder (IL-2, IL-6, TNF-alpha, BDNF). We further found a connection of the M235 polymorphism of the AGT (angiotensinogene) gene to positive family history of psychiatric illness (p=0.031). As for cognitive characteristics, we identified three subtypes with different cognitive performance profiles. This finding shows interindividual variability of cognitive style in the group of hyperkinetic boys.
650    _2
$a mladiství $7 D000293
650    _2
$a pozornost $x fyziologie $x účinky léků $7 D001288
650    _2
$a hyperkinetická porucha $x epidemiologie $x genetika $x metabolismus $7 D001289
650    _2
$a biologické markery $7 D015415
650    _2
$a stimulanty centrálního nervového systému $x terapeutické užití $7 D000697
650    _2
$a dítě $7 D002648
650    _2
$a diskriminace (psychologie) $x fyziologie $7 D004192
650    _2
$a vnímání tvaru $x fyziologie $7 D005556
650    _2
$a genetické markery $7 D005819
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methylfenidát $x terapeutické užití $7 D008774
650    _2
$a neuropsychologické testy $7 D009483
650    _2
$a fenotyp $7 D010641
650    _2
$a polymorfismus genetický $x genetika $7 D011110
650    _2
$a psychiatrické posuzovací škály $7 D011569
650    _2
$a psychomotorický výkon $x fyziologie $x účinky léků $7 D011597
650    _2
$a receptory dopaminu D2 $x genetika $7 D017448
650    _2
$a financování organizované $7 D005381
651    _2
$a Česká republika $x epidemiologie $7 D018153
700    1_
$a Šerý, Omar, $d 1972- $7 xx0060835
700    1_
$a Theiner, Pavel $7 xx0053973
700    1_
$a Fiľová, Alena, $d 1980- $7 mzk2007377414
700    1_
$a Žáčková, Markéta $7 xx0088516
700    1_
$a Balaštíková, Blanka $7 xx0061861
700    1_
$a Znojil, Vladimír, $d 1941-2008 $7 ola2003204904
773    0_
$t Neuroendocrinology Letters $w MED00168352 $g Roč. 29, č. 3 (2008), s. 320-327 $x 0172-780X
910    __
$a ABA008 $b x $y 1 $z 0
990    __
$a 20110413122230 $b ABA008
991    __
$a 20140307115704 $b ABA008
999    __
$a ok $b bmc $g 831336 $s 696021
BAS    __
$a 3
BMC    __
$a 2008 $b 29 $c 3 $d 320-327 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
GRA    __
$a NR9298 $p MZ0
LZP    __
$a 2011-3B/ipme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...